Filing Details

Accession Number:
0001179110-18-001378
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-01 17:50:01
Reporting Period:
2018-01-31
Accepted Time:
2018-02-01 17:50:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492289 J Brian Blaser 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2018-01-31 27,733 $22.39 156,587 No 4 M Direct
Common Shares Without Par Value Disposition 2018-01-31 890 $62.24 155,697 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 500 $62.24 155,197 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 1,798 $62.25 153,399 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 6,400 $62.25 146,999 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 2,931 $62.26 144,068 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 4,613 $62.26 139,455 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 2,501 $62.27 136,954 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 5,660 $62.27 131,294 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 1,340 $62.28 129,954 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 400 $62.28 129,554 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 600 $62.29 128,954 No 4 S Direct
Common Shares Without Par Value Disposition 2018-01-31 100 $62.29 128,854 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2018-01-31 27,733 $0.00 27,733 $22.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-18 2021-02-17 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.